Table 1:
Study | Technique | Mesoderm induction | Mesoderm markers | MSC phenotype | Adipocyte | Adipogenesis induction |
---|---|---|---|---|---|---|
Taura et al.73 | EB outgrowth | ES cell culture medium w/out FGF2 | Unknown | Unknown | Unknown | INS, IBMX, Dex, Indo, pioglitazone |
Ahfeldt et al.37 | EB outgrowth, transgene | DMEM, 15% FBS | GSC/TBX3 | CD73, CD105 | White | INS, Dex, Rosi, PPARG transgene |
Ahfeldt et al.37 | EB outgrowth, transgene | DMEM, 15% FBS | GSC/TBX3 | CD73, CD105 | Brown | INS, Dex, Rosi, PPARG + CEBPB transgenes |
Nishio et al.76 | EB outgrowth | BPEL medium, BMP4, VEGFA, KITLG FLT3LG, IL-6, IGF-II | MYF5, PDFGRα, PAX7, PAX3 | Unknown | Brown | BMP7, VEGFA, KITLG FLT3LG, IL-6, IGF-2 |
Mohsen-Kanson, et al.77 | EB outgrowth | DMEM/F12/20% KSR + retinoic acid | Unknown | CD73, CD105, CD90, CD146, PAX3 | White | INS, IBMX, Dex, T3, Rosi |
Mohsen-Kanson, et al.77 | EB outgrowth | DMEM/F12/20% KSR | PAX3? | CD73, CD105, CD90, CD146, PAX3 | Brown | INS, IBMX, Dex, T3, Rosi |
Hafner et al.80 | EB outgrowth | DMEM/F12/20% KSR | PAX3? | CD73, CD105, CD90 | Brown and Beige | INS, IBMX, Dex, T3, Rosi, SB431542, ascorbic acid, hydrocortisone, EGF |
Guénantin et al.84 | Monolayer | STEMPro34 HSC medium + BMP4, Activin A | TBOX, MESP1 | PDGFRα, CD44, CD29 and LY6E | Beige | INS, IBMX, Dexa, Indo |
Su et al.80 | Monolayer | STEMdiff™ Mesoderm Induction Medium | FOXF1, BAPX1, HOX11 | CD73, CD105, CD90, CD146, PDGFRβ, NG2 | Beige | INS, IBMX, Dex, Indo, T3, Rosi, SB431542, ascorbic acid, hydrocortisone, EGF |
EB – embryoid body, INS – insulin, Dex – dexamethasone, Indo – indomethacin, Rosi – Rosiglitazone, BPEL - Bovine Serum Albumin (BSA) Polyvinylalchohol Essential Lipids Medium, HSC – hematopoietic stem cell.